Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Saavedra

Showing results (101-110 of 209) with videos related to

Pageof 21
Sort By:
The Journal of Organic Chemistry|November 10, 2012
O2-functionalized methylamine diazeniumdiolates: evidence for E ⇄ Z equilibration in an acyclic systemDebanjan Biswas, Ryan J Holland, Jeffrey R Deschamps, et al.
Oral Microbiology and Immunology|August 26, 2004
In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in SpainI Tomás, M Alvarez, J Limeres, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 25, 2002
Plasma pharmacokinetics of a liver-selective nitric oxide-donating diazeniumdiolate in the male C57BL/6 mouseS F Stinson, T House, C Bramhall, et al.
Journal of Neurosurgery|October 22, 2003
Selective opening of the blood-tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomasAstrid Weyerbrock, Stuart Walbridge, Ryszard M Pluta, et al.
Oncogene|November 4, 2008
Nitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining wild-type p53J Kitagaki, Y Yang, J E Saavedra, et al.
Chemistry & Biology|December 1, 1995
Using evolutionary changes to achieve species-specific inhibition of enzyme action--studies with triosephosphate isomeraseA Gómez-Puyou, E Saavedra-Lira, I Becker, et al.
International Journal of Oncology|January 29, 2011
JS-K, a nitric oxide-releasing prodrug, induces breast cancer cell death while sparing normal mammary epithelial cellsVanity McMurtry, Joseph E Saavedra, René Nieves-Alicea, et al.
Hepatology (Baltimore, Md.)|January 24, 2003
The nitric oxide donor, V-PYRRO/NO, protects against acetaminophen-induced hepatotoxicity in miceJie Liu, Chengxiu Li, Michael P Waalkes, et al.
Bioorganic & Medicinal Chemistry|December 7, 2007
Synthesis, nitric oxide release, and anti-leukemic activity of glutathione-activated nitric oxide prodrugs: Structural analogues of PABA/NO, an anti-cancer lead compoundHarinath Chakrapani, Thomas C Wilde, Michael L Citro, et al.
Forum on Immunopathological Diseases and Therapeutics|April 16, 2013
Thiol Modification By Pharmacologically Active Agents of the Diazeniumdiolate ClassAnna E Maciag, Ryan J Holland, Joseph E Saavedra, et al.
Pageof 21

Showing results (101-110 of 209) with videos related to

Sort By:
Pageof 21
The Journal of Organic Chemistry|November 10, 2012
O2-functionalized methylamine diazeniumdiolates: evidence for E ⇄ Z equilibration in an acyclic systemDebanjan Biswas, Ryan J Holland, Jeffrey R Deschamps, et al.
Oral Microbiology and Immunology|August 26, 2004
In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in SpainI Tomás, M Alvarez, J Limeres, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 25, 2002
Plasma pharmacokinetics of a liver-selective nitric oxide-donating diazeniumdiolate in the male C57BL/6 mouseS F Stinson, T House, C Bramhall, et al.
Journal of Neurosurgery|October 22, 2003
Selective opening of the blood-tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomasAstrid Weyerbrock, Stuart Walbridge, Ryszard M Pluta, et al.
Oncogene|November 4, 2008
Nitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining wild-type p53J Kitagaki, Y Yang, J E Saavedra, et al.
Chemistry & Biology|December 1, 1995
Using evolutionary changes to achieve species-specific inhibition of enzyme action--studies with triosephosphate isomeraseA Gómez-Puyou, E Saavedra-Lira, I Becker, et al.
International Journal of Oncology|January 29, 2011
JS-K, a nitric oxide-releasing prodrug, induces breast cancer cell death while sparing normal mammary epithelial cellsVanity McMurtry, Joseph E Saavedra, René Nieves-Alicea, et al.
Hepatology (Baltimore, Md.)|January 24, 2003
The nitric oxide donor, V-PYRRO/NO, protects against acetaminophen-induced hepatotoxicity in miceJie Liu, Chengxiu Li, Michael P Waalkes, et al.
Bioorganic & Medicinal Chemistry|December 7, 2007
Synthesis, nitric oxide release, and anti-leukemic activity of glutathione-activated nitric oxide prodrugs: Structural analogues of PABA/NO, an anti-cancer lead compoundHarinath Chakrapani, Thomas C Wilde, Michael L Citro, et al.
Forum on Immunopathological Diseases and Therapeutics|April 16, 2013
Thiol Modification By Pharmacologically Active Agents of the Diazeniumdiolate ClassAnna E Maciag, Ryan J Holland, Joseph E Saavedra, et al.
Pageof 21